Open AccessStriking balance between expedited review and expecting efficacious anticancer drug and biologics: An ongoing challenge
Author(s) -
Krishnan Vengadaragava Chary,
Anita Ramesh
Publication year - 2017
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.215971
Subject(s) - medicine , adverse effect , postmarketing surveillance , drug , observational study , pharmacology , intensive care medicine
The objective of this study is to assess the postmarketing status: Efficacy and safety drugs and biologics related with cancer approved under expedited review.